Showing results (41-50 of 345) with videos related to
Sort By:
Pageof 35
American Journal of Hypertension|April 4, 2013
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levelsJean E Sealey, Michael H Alderman, Curt D Furberg, et al.Journal of Clinical Lipidology|December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular diseasePeter P Toth, George Thanassoulis, Ken Williams, et al.American Heart Journal|August 11, 2012
Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studiesDavid Madigan, Daniel W Sigelman, James W Mayer, et al.The American Journal of Cardiology|May 15, 2012
Comparison of coronary calcium screening versus broad statin therapy for patients at intermediate cardiovascular riskAllan D Sniderman, George Thanassoulis, Patrick R Lawler, et al.Journal of Clinical Lipidology|July 28, 2012
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein loweringAllan Sniderman, George Thanassoulis, Patrick Couture, et al.Current Opinion in Nephrology and Hypertension|June 29, 2023
Medication safety in chronic kidney diseaseSonal SinghCurrent Diabetes Reports|November 4, 2014
Type 2 diabetes pharmacoepidemiology update 2014: safety versus efficacySonal SinghAdolescent Health, Medicine and Therapeutics|March 7, 2014
Influencing behavioral change by customer engagement amongst youthSonal SinghTrials|November 25, 2011
Five years of TrialsDouglas G Altman, Iain Hrynaszkiewicz, Curt D Furberg, et al.Annals of Internal Medicine|July 9, 2004
ALLHAT: setting the record straightBarry R Davis, Curt D Furberg, Jackson T Wright, et al.Pageof 35